文献速递造血干细胞移植与细胞治疗

异基因干细胞移植当日Reg3α浓度预测结局并与早期抗生素使用相关

Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use.
PubMed 文献 · Blood Adv · 2023-01-01

研究分析7个德国中心587例异基因干细胞移植患者,分为单中心测试队列371例和多中心验证队列216例。移植当日高Reg3α浓度与1年移植相关死亡率升高相关(P < .001),且与早期全身抗生素治疗独立相关。

要点

  • 移植当日高Reg3α浓度与1年移植相关死亡率升高相关(P < .001)。
  • 移植当日高Reg3α浓度与早期全身抗生素治疗独立相关。
  • 高Reg3α组尿3-吲哚硫酸盐(P = .04)和梭菌目XIVa群(P = .004)较低。

核心结论

  • 移植当日血清Reg3α浓度可预测异基因干细胞移植受者的移植相关死亡风险。

研究设计与样本

  • 分析来自7个德国中心的587例患者预处理前和移植当日的临床数据及血样,分为单中心测试队列371例和多中心验证队列216例。

主要发现

  • 移植当日高Reg3α浓度在测试队列和验证队列中均与较高的1年移植相关死亡率相关(P < .001)。
  • Cox回归分析显示移植当日高Reg3α是1年移植相关死亡的独立预后因素。
  • 多变量分析显示移植当日高Reg3α浓度与早期全身抗生素治疗独立相关。
  • 高Reg3α组患者尿3-吲哚硫酸盐较低(P = .04),梭菌目XIVa群较低(P = .004)。
  • 预处理前Reg3α浓度与移植相关死亡率及疾病或治疗相关参数均不相关。

临床怎么用

  • 移植当日血清Reg3α浓度可用于预测异基因干细胞移植受者的移植相关死亡风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intestinal microbiome diversity plays an important role in the pathophysiology of acute gastrointestinal (GI) graft-versus-host disease (GVHD) and influences the outcome of patients after allogeneic stem cell transplantation (ASCT). We analyzed clinical data and blood samples taken preconditioning and on the day of ASCT from 587 patients from 7 German centers of the Mount Sinai Acute GVHD International Consortium, dividing them into single-center test (n = 371) and multicenter validation (n = 216) cohorts. Regenerating islet-derived 3α (Reg3α) serum concentration of day 0 correlated with clinical data as well as urinary 3-indoxylsulfate (3-IS) and Clostridiales group XIVa, indicators of intestinal microbiome diversity. High Reg3α concentration at day 0 of ASCT was associated with higher 1-year transplant-related mortality (TRM) in both cohorts (P < .001). Cox regression analysis revealed high Reg3α at day 0 as an independent prognostic factor for 1-year TRM. Multivariable analysis showed an independent correlation of high Reg3α concentrations at day 0 with early systemic antibiotic (AB) treatment. Urinary 3-IS (P = .04) and Clostridiales group XIVa (P = .004) were lower in patients with high vs those with low day 0 Reg3α concentrations. In contrast, Reg3α concentrations before conditioning therapy correlated neither with TRM nor disease or treatment-related parameters. Reg3α, a known biomarker of acute GI GVHD correlates with intestinal dysbiosis, induced by early AB treatment in the period of pretransplant conditioning. Serum concentrations of Reg3α measured on the day of graft infusion are predictive of the risk for TRM of ASCT recipients.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Weber D, Weber M, Meedt E, et al. Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use. Blood Adv. 2023. PMID: 36350750. doi:10.1182/bloodadvances.2022008480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。